PMC:7441788 / 37246-37495 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T148","span":{"begin":80,"end":89},"obj":"Disease"},{"id":"T149","span":{"begin":106,"end":114},"obj":"Disease"}],"attributes":[{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T271","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T382","span":{"begin":182,"end":194},"obj":"Chemical"}],"attributes":[{"id":"A382","pred":"chebi_id","subj":"T382","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T219","span":{"begin":182,"end":194},"obj":"Chemical"}],"attributes":[{"id":"A219","pred":"chebi_id","subj":"T219","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T135","span":{"begin":106,"end":114},"obj":"Species"}],"attributes":[{"id":"A135","pred":"ncbi_taxonomy_id","subj":"T135","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T256","span":{"begin":0,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1346","span":{"begin":33,"end":41},"obj":"Species"},{"id":"1371","span":{"begin":55,"end":58},"obj":"Chemical"},{"id":"1372","span":{"begin":182,"end":194},"obj":"Chemical"},{"id":"1411","span":{"begin":80,"end":89},"obj":"Disease"},{"id":"1412","span":{"begin":106,"end":114},"obj":"Disease"},{"id":"1413","span":{"begin":136,"end":152},"obj":"Disease"}],"attributes":[{"id":"A1346","pred":"pubann:denotes","subj":"1346","obj":"Tax:9606"},{"id":"A1371","pred":"pubann:denotes","subj":"1371","obj":"MESH:D006886"},{"id":"A1372","pred":"pubann:denotes","subj":"1372","obj":"MESH:D017963"},{"id":"A1411","pred":"pubann:denotes","subj":"1411","obj":"MESH:D011014"},{"id":"A1412","pred":"pubann:denotes","subj":"1412","obj":"MESH:C000657245"},{"id":"A1413","pred":"pubann:denotes","subj":"1413","obj":"MESH:D008133"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T141","span":{"begin":80,"end":89},"obj":"Disease"},{"id":"T142","span":{"begin":106,"end":114},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T36","span":{"begin":80,"end":89},"obj":"Phenotype"}],"attributes":[{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1346","span":{"begin":33,"end":41},"obj":"Species"},{"id":"1371","span":{"begin":55,"end":58},"obj":"Chemical"},{"id":"1372","span":{"begin":182,"end":194},"obj":"Chemical"},{"id":"1411","span":{"begin":80,"end":89},"obj":"Disease"},{"id":"1412","span":{"begin":106,"end":114},"obj":"Disease"},{"id":"1413","span":{"begin":136,"end":152},"obj":"Disease"}],"attributes":[{"id":"A1346","pred":"tao:has_database_id","subj":"1346","obj":"Tax:9606"},{"id":"A1371","pred":"tao:has_database_id","subj":"1371","obj":"MESH:D006886"},{"id":"A1372","pred":"tao:has_database_id","subj":"1372","obj":"MESH:D017963"},{"id":"A1411","pred":"tao:has_database_id","subj":"1411","obj":"MESH:D011014"},{"id":"A1412","pred":"tao:has_database_id","subj":"1412","obj":"MESH:C000657245"},{"id":"A1413","pred":"tao:has_database_id","subj":"1413","obj":"MESH:D008133"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T256","span":{"begin":0,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T37","span":{"begin":80,"end":89},"obj":"Phenotype"}],"attributes":[{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"A recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithromycin was associated with greater changes in QTc (21%) [68]."}